U.S. Pharma Stock News

Mercury Systems (NasdaqGS:MRCY) has acquired SolderMask, Inc., adding specialized manufacturing capabilities and intellectual property. The deal brings in skilled personnel and assets that directly support more than 20 active Mercury programs tied to critical defense work. The acquisition is intended to accelerate production efficiency and strengthen delivery commitments across key customer contracts. Mercury Systems, trading at $78.16, has seen a 68.0% return over the past year and a 69.1%...

Kymera Therapeutics recently advanced its first IRF5-directed oral therapy, KT-579, into human clinical testing and reported Phase 1b data for its oral STAT6 degrader KT-621, which appeared comparable or better than injectable dupilumab in a large inflammatory disease market. This progress positions Kymera as a pioneer in oral protein degraders that aim to match biologic-like efficacy while potentially offering more convenient, small-molecule treatment options. We’ll now examine how Kymera’s...

If you are wondering whether Tetra Tech shares are offering fair value right now, this article walks through what the current price could mean for long term investors. The stock last closed at US$32.18, with a 7.7% decline over the past week, a 20.4% decline over the past month, and returns of 11.3% over 1 year, 17.9% over 3 years, and 28.8% over 5 years. Recent coverage has focused on Tetra Tech as a US listed commercial services company and on how its current share price compares with...

Madrigal Pharmaceuticals recently reported that its MASH drug Rezdiffra generated nearly US$1.00 billion in its first full year on the market, reinforcing the company’s leading position in this disease area. This rapid commercial traction, coupled with management’s expectation for continued robust net sales growth in 2026, has attracted heightened attention from both institutional investors and short-sellers. Next, we’ll examine how Rezdiffra’s nearly US$1.00 billion first-year sales...

If you are wondering whether Piper Sandler Companies' current share price really reflects its underlying worth, or if the recent run leaves room for value, this article walks through that question step by step. The stock last closed at US$282.30, with returns showing a 3.8% decline over 7 days, a 17.4% decline over 30 days, a 19.3% decline year to date, a 14.2% gain over 1 year and a very large 3 year and 5 year return. Recent coverage around Piper Sandler Companies has focused on its role...

HubSpot (HUBS) is back on investor radars after a recent share price move, with the stock closing at $264.30 and showing mixed returns across the past week, month, and past 3 months. See our latest analysis for HubSpot. That 2.59% 1 day share price gain to US$264.30 comes after a 26.26% 30 day share price return. However, the year to date share price return and 1 year total shareholder return are both sharply negative, hinting that recent momentum is more of a rebound than a sustained...

Unity Software (NYSE:U) has seen significant insider selling activity while reporting expanding operating margins. At the same time, the company is working through revenue growth challenges that have drawn fresh attention from investors. The mix of insider sales, margin improvement, and pressure on growth is raising new questions about Unity's internal outlook and business direction. For investors watching Unity Software at a share price of $19.43, the recent pattern of insider selling...

Insight Enterprises (NSIT) has been drawing attention after recent share price pressure, including a 10.2% decline over the past month. This has prompted investors to revisit how its current valuation lines up with underlying fundamentals. See our latest analysis for Insight Enterprises. Putting the recent 10.2% 1 month share price decline in context, Insight Enterprises now sits at US$80.86. The 1 year total shareholder return is 46.6% in the red and multi year total returns are also under...

What recent performance numbers say about FirstEnergy (FE) With no single headline event driving attention, FirstEnergy (FE) is back on investors’ radars after a recent share price move. This interest is supported by reported revenue of US$14.9b and net income of US$1.02b. See our latest analysis for FirstEnergy. At a share price of US$51.16, FirstEnergy has delivered a 6.74% 1 month share price return and a 15.59% 3 month share price return, while the 1 year total shareholder return of...

In early March 2026, LifeMD, Inc. reported that it moved from a US$21.41 million annual net loss in 2024 to US$14.35 million net income in 2025, issued double‑digit revenue growth guidance for 2026, and highlighted expanding telehealth offerings including its oral Wegovy weight management launch with Novo Nordisk. This shift to profitability, combined with more than 322,000 active subscribers and growing GLP‑1 and women’s health programs, signals a business model that is scaling across...

If you are wondering whether NetApp's share price really reflects what the business is worth today, you are not alone. That is exactly what this article will unpack. NetApp shares last closed at US$98.66, with returns of 9.5% over 1 year, 71.3% over 3 years and 58.3% over 5 years. However, the stock has seen a 2.4% decline over 7 days, 6.8% over 30 days and 7.3% year to date. Recent company specific headlines have continued to keep investor attention on NetApp, helping frame how the market...

If you are wondering whether CoreCivic's share price really reflects what the business is worth, you are not alone. This article is written with that question in mind. CoreCivic's stock closed at US$18.21 most recently, with returns of 0.8% over 7 days, a 1.6% decline over 30 days, a 4.3% decline year to date and a 10.4% decline over the past year, while the 3 year and 5 year returns sit at 102.8% and 97.5% respectively. These mixed returns have put more attention on how the market is...

Johnson & Johnson (NYSE:JNJ) reported strong Phase 1 results for its intravesical erdafitinib drug releasing system in non muscle invasive bladder cancer. The program showed high response rates, durable remission, and an encouraging safety profile in intermediate and high risk patients. The data support moving the Erda iDRS program into late stage development as a localized treatment approach. For investors watching NYSE:JNJ, this update adds a fresh piece of information to the company...

PGIM, the global investment management arm of Prudential Financial (NYSE:PRU), received multiple 2026 LSEG Lipper Fund Awards. The awards recognize consistent, risk adjusted performance across PGIM funds. The recognition extends Prudential Financial's record of industry accolades for its asset management platform. For a company often associated first with insurance and annuities, these LSEG Lipper Fund Awards put a spotlight on a different side of Prudential Financial: its global asset...

WM Technology (MAPS) closed out FY 2025 with Q4 revenue of about US$43.1 million and a basic EPS loss of roughly US$0.03, while trailing twelve month EPS stood at around US$0.02 on revenue of roughly US$174.7 million. Over recent periods the company has seen quarterly revenue range between about US$42.2 million and US$47.7 million, with EPS moving from a profit of roughly US$0.03 per share in late 2024 to small profits through most of 2025 before the latest quarterly loss. This has left...

Delek US Holdings (DK) is back in focus after reporting fourth quarter 2025 adjusted EPS of $2.31 versus a forecast loss of $0.07, even though quarterly revenue trailed expectations. See our latest analysis for Delek US Holdings. Despite a small 1-day share price decline of 0.57% to US$41.72, Delek US Holdings has seen strong recent momentum, with a 30-day share price return of 20.86% and a 1-year total shareholder return of roughly 1.8x. This suggests investors are reassessing its risk and...

If you are wondering whether Moelis shares offer good value at today's price, it helps to step back and look at what the current market is implying about the business. The stock last closed at US$51.75, after a 7.8% decline over the past week, a 25.1% decline over the past month, and a 27.3% decline year to date, while still showing a 51.6% return over 3 years and 23.6% over 5 years. These recent moves have kept Moelis on investors' radars, with market commentary often linking advisory firms...

Why Utz Brands Stock Is On Investors’ Radar Utz Brands (UTZ) has drawn fresh attention after a sharp share price pullback, with the stock around $7.56 and showing negative returns over the past month and past 3 months. See our latest analysis for Utz Brands. The recent pullback has been steep, with a 30 day share price return of a 32.08% decline and a 90 day share price return of a 26.10% decline. Over the longer term, the 1 year total shareholder return of a 41.97% decline points to...

Immunic, Inc. recently secured a key European patent for its lead asset vidofludimus calcium, aligning protection with existing U.S. coverage and potentially extending exclusivity into the 2040s for chronic inflammatory and autoimmune indications. This expanded intellectual property protection materially underpins the company’s core therapeutic franchise by lengthening its runway to develop and, if approved, commercialize its main clinical asset. Against this backdrop, we’ll explore how the...

If you are wondering whether Futu Holdings is attractively priced or getting ahead of itself, this article will walk through what the current share price might be implying about its value. The stock last closed at US$141.14, with returns of 19.1% over 1 year and a very large 3 year gain. However, the year to date return sits at a 20.9% decline and the 30 day return at an 8.8% decline. Recent coverage has focused on Futu Holdings as a major online brokerage name listed on the Nasdaq, with...

Precision BioSciences (DTIL) closed out FY 2025 with Q4 revenue of US$34.2 million and Basic EPS of US$1.01, alongside earnings from discontinued operations of US$0.9 million and net income excluding extra items of US$19.2 million. Over recent quarters, the company has seen revenue range from US$0.6 million in Q4 2024 to US$34.2 million in Q4 2025. Over the same period, quarterly Basic EPS has moved from a loss of US$2.22 in Q4 2024 to a profit of US$1.01 in Q4 2025. This sets up an earnings...

Star Bulk Carriers recently attracted investor attention after appearing among Zacks.com’s most searched stocks and participating in Capital Link’s online maritime company presentations, where management discussed its business development, strategy, and sector outlook in a live webinar and Q&A. This combination of heightened visibility and a stable earnings outlook, including expectations for significant year-over-year earnings growth, has sharpened focus on how management’s messaging aligns...

Assurant, Inc. reported fourth-quarter 2025 net operating income and revenue above analyst estimates, driven by higher premiums and growth in its Global Housing and Global Lifestyle segments, and outlined 2026 adjusted EBITDA expectations that are consistent with or higher than 2025 alongside continued capital returns to shareholders. Separately, Assurant expanded access to its Reynolds and Reynolds docuPAD eContracting training program and announced that experienced financial services...

TIC Solutions (NYSE:TIC) has appointed Ben Heraud as its new CEO, succeeding long-serving leader Tal Pizzey. The company has also launched a $200 million share repurchase program. These changes were recently announced and have not been widely discussed in prior coverage. TIC Solutions is making these moves at a time when its share price is $7.25, with the stock showing a 40.3% decline over the past year and a 26.7% decline year to date. The new leadership and buyback plan arrive against...